Notably, a study revealed significantly increased mRNA expression of ACE2 and TMPRSS2, key molecules involved in SARS-CoV-2 cell entry, in the livers of patients with advanced nonalcoholic fatty liver disease (NAFLD) (38). This evidence concerns the gene ACE2 and metabolic dysfunction-associated steatotic liver disease.